Publication Name	World Journal of Diabetes
Manuscript ID	19194
Country	Japan

Received	2015-05-01 14:23
Peer-Review Started	2015-05-03 22:21
To Make the First Decision	2015-06-18 16:13
Return for Revision	2015-06-24 15:47
Revised	2015-07-06 00:00
Second Decision	2015-07-17 08:32
Accepted by Journal Editor-in-Chief	2015-07-17 23:34
Accepted by Executive Editor-in-Chief	2015-07-27 17:19
Articles in Press	2015-07-27 17:19
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-08-21 18:19
Publish the Manuscript Online	2015-08-26 20:56

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Editorial
Article Title	Effect of proton pump inhibitors on glycemic control in patients with diabetes
Manuscript Source	Invited Manuscript
All Author List	Kohzo Takebayashi and Toshihiko Inukai
Funding Agency and Grant Number
Corresponding Author	Kohzo Takebayashi, MD, Department of Internal Medicine, Dokkyo Medical University Koshigaya Hospital, 2-1-50 Minamikoshigaya, Koshigaya, Saitama 343-8555, Japan. takeb@gmail.plala.or.jp
Key Words	Gastrin; Proton pump inhibitors; Glycemic control; Type 2 diabetes
Core Tip	Recently, it is reported that gastrin may improve glucose tolerance mainly by the promotion of pancreatic cell neogenesis. Proton pump inhibitors (PPIs) are wildly used clinically for the treatment such as gastric ulcers, and it is known that PPIs indirectly elevate serum gastrin levels. Recent evidence has showed the beneficial effect of PPIs on glycemic control especially in patients with type 2 diabetes, probably via the elevation of serum gastrin levels. Therefore, PPIs may have the potential to be candidates for a new approach in the treatment of diabetes.
Publish Date	2015-08-26 20:56
Citation	Takebayashi K, Inukai T. Effect of proton pump inhibitors on glycemic control in patients with diabetes. World J Diabetes 2015; 6(10): 1122-1131
URL	http://www.wjgnet.com/1948-9358/full/v6/i10/1122.htm
DOI	http://dx.doi.org/10.4239/wjd.v6.i10.1122

Full Article (PDF)	WJD-6-1122.pdf
Full Article (Word)	WJD-6-1122.doc
Manuscript File	19194-Review.doc
Answering Reviewers	19194-Answering reviewers.pdf
Audio Core Tip	19194-Audio core tip.wav
Conflict-of-Interest Disclosure Form	19194-Conflict-of-interest statement.pdf
Copyright License Agreement	19194-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	19194-Language certificate.pdf
Peer-review Report	19194-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	19194-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	19194-Scientific misconduct check.pdf
Scientific Editor Work List	19194-Scientific editor work list.pdf